Chapter 51: Diuretic Agents

Diuretic Agents outlines the critical role of diuretic agents, which are medications primarily designed to enhance the excretion of sodium ions—and subsequently water—by inhibiting reabsorption in the renal tubules, thereby reducing intravascular fluid volume and hydrostatic pressure. These drugs are essential in treating conditions involving volume overload and high pressure, including hypertension, edema linked to heart failure (HF), acute pulmonary edema, severe liver disease (such as cirrhosis), and various renal disorders, as well as decreasing intraocular pressure (IOP) in glaucoma. The five main pharmacological classifications of diuretics include the Thiazide and Thiazide-Like diuretics, Loop diuretics, Carbonic Anhydrase Inhibitors (CAIs), Potassium-Sparing diuretics, and Osmotic diuretics. Thiazide agents, such as hydrochlorothiazide, are considered mild saluretics that block the chloride pump in the distal tubule, leading to sodium-rich urine and serving as first-line therapy for essential hypertension. In contrast, Loop diuretics, known as high-ceiling diuretics and including furosemide, act powerfully in the loop of Henle to block chloride pumps, causing rapid, copious diuresis; they are reserved for acute situations like pulmonary edema or severe edema unresponsive to milder agents. CAIs, like acetazolamide, inhibit carbonic anhydrase, leading to the loss of bicarbonate and resulting in alkaline urine, commonly used to decrease aqueous humor secretion in glaucoma. Potassium-Sparing diuretics, such as spironolactone, are mild adjuncts that cause sodium loss while promoting potassium retention; spironolactone is specifically indicated for hyperaldosteronism. Finally, osmotic diuretics, exemplified by mannitol, are administered intravenously to exert an osmotic pull that draws large amounts of fluid from extravascular spaces into the circulation and subsequently into the renal tubule, making them the drug of choice for rapidly decreasing intracranial pressure and IOP. General adverse effects across these classes involve gastrointestinal upset and fluid or electrolyte imbalances, such as hypotension. Specific risks include hypokalemia with loop and thiazide diuretics, hyperkalemia with potassium-sparing agents, and ototoxicity with loop diuretics. Patients must maintain adequate fluid intake to avoid the dangerous compensatory response known as fluid rebound. Nursing care involves critical monitoring of daily weight, serum electrolytes (especially potassium and glucose), hydration status, and educating patients on dietary adjustments specific to whether the drug causes potassium wasting or potassium sparing.